MedPath

UNASYN

UNASYN (ampicillin sodium/sulbactam sodium)

Approved
Approval ID

12eeb72a-403d-41be-bae4-4cb930862884

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 6, 2023

Manufacturers
FDA

Roerig

DUNS: 829076996

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ampicillin sodium and sulbactam sodium

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0049-0024
Application NumberNDA050608
Product Classification
M
Marketing Category
C73594
G
Generic Name
ampicillin sodium and sulbactam sodium
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateMarch 29, 2023
FDA Product Classification

INGREDIENTS (2)

AMPICILLIN SODIUMActive
Quantity: 100 mg in 1 mL
Code: JFN36L5S8K
Classification: ACTIM
SULBACTAM SODIUMActive
Quantity: 50 mg in 1 mL
Code: DKQ4T82YE6
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

UNASYN - FDA Drug Approval Details